Eleven new recommendations were issued to address appropriate HER2 testing and clinical guidance in individuals with advanced gastroesophageal adenocarcinoma.
The company's technology will be used to analyze samples from a large cohort of Chinese volunteers to identify biomarkers for early cancer detection.
In PNAS this week: gene mutations linked to gastric cancer development, genetic determinants that influence reward processing, and more.
The three organizations are inviting comment from health professionals on the recommendations.
Along with breast, ovarian, and pancreatic cancers, the "signature 3" mutation pattern was detected in around 10 percent of sequenced gastric tumors.
In PNAS this week: regenerative flatworm genome, transmission patterns of autism-linked de novo mutations, and more.
The researchers used a method known as paired-end tag sequencing, or DNA-PET, to identify five recurrent gene fusions in Asian populations with gastric cancer.
New loss-of-function mutations in a gene called ATM were implicated in gastric cancer risk, based on genotyping profiles for thousands of gastric cancer cases and controls in Iceland.
The research also uncovered other mutations that might be associated with these cancers in patients who do not have a CDH1 mutation.
The non-invasive, blood-based circulating tumor cell and circulating tumor DNA cancer tests will be made available to 19 million patients.
HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.
The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.
In Nature this week: glioma GWAS uncovers new risk loci, and more.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.